Raoul S. Concepcion, MD, FACS

U.S. Urology Partners

Nolensville, Tennessee

Raoul S. Concepcion, MD, FACS, is the Chief Science Officer of U.S. Urology Partners in Nolensville, Tennessee. He was a resident in General Surgery and Urology at Vanderbilt University from 1984-1990, and later served as a Clinical Associate Professor of Urology there.

Dr. Concepcion’s clinical interests revolve around advanced prostate and bladder cancer management. He is a past President of LUGPA. Along with two other urologists, he founded CUSP, a urologic research consortium in the United States. Additionally, he is an advisor and/or speaker for many companies, including Dendreon, Pfizer, Astellas, Amgen, Cellay, and Janssen, and has served as editor for Urologists in Cancer Care.

Disclosures:

Speakers Bureau Member: Astellas, Amgen, Pfizer
Advisory Committee Member: Dendreon, Clovis
Consultant: Merck, Invitae, CUSP PharmaTech Consulting, Cellay, Sun Pharmaceutical Industries, Integra Connect
Honorarium Recipient: Dendreon, Clovis, Merck, Invitae, CUSP PharmaTech Consulting, Cellay, Sun Pharmaceutical Industries, Integra Connect